
US vaccination rates for measles, other diseases drop further, government data says
The U.S. Centers for Disease Control and Prevention released the new figures at a time when the country faces a growing measles outbreak, with confirmed cases this month reaching the highest level since the disease was declared eliminated from the country in 2000.
Secretary of Health and Human Services Robert F. Kennedy Jr. has long questioned the safety of vaccines, contrary to scientific evidence, and he has also suggested a link between vaccines and autism.
The CDC data show vaccination rates have steadily trended down since the COVID-19 pandemic. For the measles, mumps and rubella vaccine, coverage went from 95.2% in the 2019-2020 school year to 92.7% last year, before landing at 92.5% in 2024-2025. In Texas, the epicenter of the recent outbreak, MMR coverage has fallen to 93.2% from 96.9% in 2019.
Most people are protected from measles through herd immunity when more than 95% of people in the community are vaccinated, the CDC website says.
An HHS spokesperson said the data released on Thursday showed a 'majority' of children continue to get routine childhood immunizations, and that vaccination remains the most effective way to protect children from measles and whooping cough.
'The decision to vaccinate is a personal one,' the spokesperson said. 'Parents should consult their healthcare providers on options for their families.'
In addition, exemptions from one or more vaccines increased to 3.6% in 2024-2025 from 3.3% the year before, the CDC website said. Exemptions, which can be granted on medical or religious grounds, increased in 36 states and DC, with 17 states reporting exemptions exceeding 5 percent, it said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
an hour ago
- Time of India
RFK Jr. is targeting 7-OH, Kratom? What are these and how do they affect the body?
Image credits: Getty Images After a viral TikTok video and a press conference with Robert F. Kennedy Jr., kratom, a plant ingredient, is in the spotlight. But what is it and how does it affect the body? Find out below! What is Kratom? According to the Department of Drug Enforcement Administration, kratom is a tropical tree native to Southeast Asia. Its leaves consist of two major psychoactive ingredients, mitragynine and 7-hydroxymitragynine, which are known to produce stimulant effects in low doses and sedative effects in high doses. Additionally, it can lead to psychotic symptoms and psychological and physiological dependence. What are the forms of kratom? Also known as thang, kakuam, thom, ketum and biak, kratom is used in various forms such as tablets, capsules, powder, or extract. How does kratom affect the body? At low doses, kratom can lead to increased alertness, physical energy, and talkativeness. At higher doses, it can lead to hallucinations, delusions and confusion. However, apart from such effects and addiction, kratom use causes numerous harmful effects such as nausea, itching, sweating, constipation, increased urination, vomiting, drowsiness and loss of appetite. Other effects include anorexia, weight loss, insomnia, hepatoxicity, and seizures. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Use an AI Writing Tool That Actually Understands Your Voice Grammarly Install Now Undo Is kratom use increasing in the US? Image credits: Getty Images In the United States, the abuse of kratom has increased in the last few years. The ability of companies to put large amounts of the ingredient into otherwise innocuous-looking products has made it more susceptible to abuse, said Dr Timothy Fong, a UCLA addiction psychiatrist, to USA TODAY. "At its core, this is a plant that's been around thousands of years," Fong added. "It has been used in Southeast Asia, chewing on the leaf as a stimulant, as a way of pain relief. And now, through vast modern technology, we've created the ability to have, what I call, fast-food kratom, if you will. Different formulations. Capsules. Powders. Teas. Gummies. Smokable versions. All sorts of different things." The use of kratom has gone viral through a TikTok video where a content creator described how a teenage boy tried stealing his wallet outside a gas station after he refused to go inside to buy the boy a Feel Free tonic consisting of kratom. While earlier, Botanic Tonics, the creator of the drink, marketed the kratom tonic as a healthy alternative to alcohol in May 2024, it announced the addition of a 21-and-over restriction to its products after settling an $8.75 million class-action lawsuit. How do kratom and 7-OH differ? Kratom is the name of the complete plant ingredient, whereas 7-OH or 7-Hydroxymitragynine is its chemical by-product. While some products are derived from the entire plant, others are formulated with high amounts of 7-OH. What has RFK Jr. said about kratom and 7-OH? During a press conference on July 29, Martin Makary, Food and Drug Administration commissioner, announced the organisation's intention to crack down on products containing 7-OH. However, he also made it clear that the by-product is the organisation's focus and not kratom overall. Alongside Robert F. Kennedy Jr., Makary announced their plan to initiate the process to have 7-OH schedules as an illicit substance. "I spent 14 years as a heroin addict, and I've been 43 years in recovery," Kennedy said during the press conference. "I've had iron willpower for most of my life. ... This compulsion was absolutely impervious to my will, and part of the problem was just the availability."


Time of India
2 hours ago
- Time of India
28 ventilators lie idle in Hazaribag hosp since 2020, superintendent assures action
1 2 Hazaribag: Since the height of the Covid-19 in 2020, 28 life-saving ventilators have been gathering dust in the ICU of Sheikh Bhikhari Medical College Hospital, unused and forgotten, Hazaribag's Sadar MLA, Pradip Prasad, has raised alarm over this critical healthcare oversight at the health unit. These machines, purchased to combat the pandemic, have yet to see the light of day, leaving patients in dire need to be referred to Ranchi for critical care. Prasad has called this not just negligence but a dangerous gamble with the lives of those seeking medical help. He has demanded swift action from the state health department to rectify this oversight immediately. Speaking to TOI, Prasad said, "These ventilators have been sitting idle for years. No steps were taken to operationalise them, nor was there any effort to appoint trained operators. This is a grave disservice to our community." Prasad also highlighted shone a light on other pressing issues plaguing the hospital, including cleanliness, a shortage of medicines, poorly maintained equipment, and a lack of staff. He stressed the urgent need for solutions. In response to Prasad's concerns, his team met with the hospital superintendent, Dr Anukaran Purti, to delve into these issues. They discussed the hospital's current system, resource status, and the challenges faced on the ground. Purti, acknowledging the gravity of the situation, promised swift action. "I will address these issues, including the ventilators, to ensure they are operational soon," he said.
&w=3840&q=100)

Business Standard
3 hours ago
- Business Standard
WHO updates recommendations on use of antibiotics for Covid-19 patients
The WHO has recommended against the use of antibiotics even in patients with severe Covid when a concurrent bacterial infection is not suspected. The global health body has released updated recommendations for the clinical management of people with Covid which, it said, are based on evidence generated from recent meta-analysis of outcomes of patients treated with antibiotics for Covid. "For patients with non-severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, we recommend no empirical antibiotics. For patients with severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, we suggest no empirical antibiotics," the WHO said. The WHO said that as COVID-19 epidemiology and severity have changed, and as emergency measures have subsided, the evidence behind a number of recommendations has changed. In parallel, evolution of health systems and the global environment have meant that the recommendations are implemented in a very different context in 2024 compared to 2020. These guidelines have evolved from the first version in 2020 in line with new information and changing circumstances of the pandemic, the WHO said. "Notable changes to COVID-19 disease over this time have been overall reduced infection rates and reduced disease severity. Emergency measures which were imposed have also been removed, and care for patients with COVID-19 has become more integrated with usual healthcare systems. "This different environment has prompted a review of the scope and content of all existing guidance. In order to maintain a clear focus and relevance, we have removed recommendations which would be considered general medical principles, and those which are no longer specific to the management of COVID-19," the WHO said. The new recommendations on use of antibiotics were prompted by the publication of data from a systematic review and meta-analysis, and the pressing need to address antimicrobial resistance. The WHO said that the updated guidelines are for people directly or indirectly involved in the health care of patients with COVID-19 and post COVID-19 condition. This includes clinicians, allied health care workers, facility managers and hospital administrators. The SARS-CoV-2 continues to infect several thousands of people daily leading to preventable morbidity and mortality across the world, the WHO said. The roll-out of vaccines and treatment for COVID-19, and increasing population immunity from infection has substantially reduced hospitalization, severity of disease, and mortality. "However, the virus continues to evolve in terms of infectivity, immune escape, and disease severity. This guideline robustly and transparently addresses the changing landscape and evidence availability, and the continual development of treatment and management strategies for COVID-19," the WHO stated. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)